Publications

2023


Pervanidou, Panagiota, Chatzidaki, Evi, Nicolaides, Nicolas C., Voutetakis, Antonis, Polychronaki, Nektaria, Chioti, Vassiliki, Kitani, Rosa-Anna, Kyrkopoulou, Eleni, Zarkogianni, Konstantia, Kalafatis, Eleftherios, Mitsis, Kostas, Perakis, Κonstantinos, Nikita, Konstantina, Kanaka-Gantenbein, Christina. “The Impact of the ENDORSE Digital Weight Management Program on the Metabolic Profile of Children and Adolescents with Overweight and Obesity and on Food Parenting Practices”. Nutrients, vol. 15, 2023.
Zarkogianni, Konstantia, Chatzidaki, Evi, Polychronaki, Nektaria, Kalafatis, Eleftherios, Nicolaides, Nicolas C., Voutetakis, Antonis, Chioti, Vassiliki, Kitani, Rosa-Anna, Mitsis, Kostas, Perakis, Κonstantinos, Athanasiou, Maria, Antonopoulou, Danae, Pervanidou, Panagiota, Kanaka-Gantenbein, Christina, Nikita, Konstantina. “The ENDORSE Feasibility Study: Exploring the Use of M-Health, Artificial Intelligence and Serious Games for the Management of Childhood Obesity”. Nutrients, vol. 15, 2023.

2022


Vasilakis, I. A., Kosteria, I., Papavasileiou, G., Zarkogianni, K., Kalafatis, L., Mitsis, K., Athanasiou, M., Perakis, K., Taliou, A., Nicolaides, N., Chioti, V., Tokou, I., Vergeti, D., Antonopoulou, D., Papachristou, E., Meklis, V., Nikita, K., Kanaka-Gantenbein, C.. “The ENDORSE feasibility pre-pilot trial: Assessing an innovative integrated platform, implementing serious games strategy and artificial intelligence-based telemedicine for glycemic control improvement”. Pediatric Diabetes, pp. 65--65, 2022.
Vasilakis, I. A., Kosteria, I., Mitsis, K., Zarkogianni, K., Kalafatis, L., Athanasiou, M., Perakis, K., Papavasiliou, G., Taliou, A., Nicolaides, N., Chioti, V., Tokou, I., Vergeti, D., Antonopoulou, D., Papachristou, E., Meklis, V., Nikita, K., Kanaka-Gantenbein, C.. “THE ENDORSE FEASIBILITY PILOT TRIAL: ASSESSING THE IMPLEMENTATION OF SERIOUS GAMES STRATEGY AND ARTIFICIAL INTELLIGENCE- BASED TELEMEDICINE IN GLYCEMIC CONTROL IMPROVEMENT”. Diabetes Technology and Therapeutics, pp. A218--A219, 2022.